by David Merkel, Aleph Blog In his annual report, though not his more well-known letter, Buffett talked about intrinsic value. It was on ...Read more Comments Off on David Merkel: On Intrinsic Value
by Joshua Brown, The Reformed Broker The 2013 Berkshire Hathaway annual letter to shareholders came out over the weekend and, as usual, it’s ...Read more Comments Off on 8 Things I Learned from Warren Buffett this Weekend
One of the responses to my last post on valuing young companies was that even if you can value companies early in the ...Read more Comments Off on "The More Comfortable You are in Valuing a Company, the Less Point There is to Doing that Valuation"
by Tony Scherrer, CFA, Director of Research & Portfolio Manager, Smead Capital Management Each year we are reminded of the fact that active ...Read more Comments Off on The Underperformance Culprit: Active Management or Active Managers?
"Exponential Business Success" by William Smead, Smead Capital Management At a major conference in November of 2012, the futurist, Peter Diamandis, shared the ...Read more Comments Off on William Smead: Investment Outlook (September 4, 2013)
Employer Mandate: A Pharma Bump in the Road by William Smead, Smead Capital Management As long-duration value investors, we at Smead Capital Management ...Read more Comments Off on Big Pharma's Political Concerns Make For Good Buying Opportunity